UroGen Pharma Ltd. Kaplan Fox Announces an Investigation into UroGen Pharma Ltd. (URGN) for Potential Securities Law Violations… Read MoreJoin Investigation
Iovance Biotherapeutics, Inc. Kaplan Fox Alerts Investors to a Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA) – Deadline is July 14, 2025… Read MoreJoin Investigation
1-800-Flowers.com Kaplan Fox Announces an Investigation into 1-800-FLOWERS.COM, Inc. for Potential Securities Law Violations… Read MoreJoin Investigation
SelectQuote and GoHealth, Inc. Kaplan Fox & Kilsheimer LLP is Investigating SelectQuote and GoHealth following the DOJ’s Allegation of a Kickback Scheme involving SLQT and GOCO… Read MoreJoin Investigation
Take-Two Interactive Software, Inc. Kaplan Fox & Kilsheimer LLP is Investigating Take-Two Interactive Software, Inc. (NASDAQ: TTWO) for Potential Securities Law Violations… Read MoreJoin Investigation
Landstar System, Inc. Kaplan Fox & Kilsheimer LLP is Investigating Landstar Systems, Inc. (LSTR) for Potential Securities Law Violations… Read MoreJoin Investigation
ICU Medical, Inc. Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations… Read MoreJoin Investigation
Aldeyra Therapeutics, Inc. Kaplan Fox & Kilsheimer LLP is Investigating Aldeyra Therapeutics, Inc. (ALDX) for Potential Securities Law Violations… Read MoreJoin Investigation